Zaytoun, O.M., Vargo, E.H., Rajan, R., Berglund, R., Gordon, S. and Jones, J.S. (2011) Emergence of Fluoroquinolone-Resistant Escherichia coli as Cause of Postprostate Biopsy Infection: Implications for Prophylaxis and Treatment. Urology, 77, 1035-1041.
https://doi.org/10.1016/j.urology.2010.12.067

has been cited by the following article:

• TITLE: Spondylodiscitis, an Exceptional Complication of Prostate Biopsy: Case Report

  AUTHORS: Abd el Kader Moumouni, Tchilabalo Matchonna Kpatcha, Massaga Dagbe, Katanga Anthony Beketi, Mawouto Akpalou, Gnimdou Botcho, Komi Hola Sikpa, Detema Wenkouda Maba, Fabie Opeku, Komi Awume, Bidamin Ntimon, Tchin Darre

  KEYWORDS: Spondylodiscitis, Prostate Biopsy, Complication

  JOURNAL NAME: Open Journal of Modern Neurosurgery, Vol.11 No.2, April 27, 2021

  ABSTRACT: Background: Transrectal prostate biopsy is a major prostate cancer diagnosis procedure that can cause infectious complications. Osteoarticular localization is uncommon. Aim: To report a case of spondylodiscitis due to a transrectal prostate biopsy and highlight therapeutical principles. Case Presentation: A 60-year-old male underwent transrectal prostate biopsy performed because of high PSA level, and presented 48 hours later with back pain, fever at 40°C associated with an obnubilation. He was treated for malaria without favorable evolution. Persistance of pain and occurrence of neurologic manifestations motivated dorso-lumbar Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) which permitted diagnosis of spondylodiscitis. The treatment was made by triple antibiotic therapy combining Imipenem 500 mg/8h (IV); Ofloxacin 200 mg/12h (IV) and Metronidazole 500 mg/8h (IV) over four weeks. Evolution under treatment was favorable. Conclusion: Spondylodiscitis is an exceptional complication of transrectal prostate biopsy. It may be evocated in case of bones pain after prostate biopsy.